Funding Update: 2013 – 2015 September 10, 2013 1.

Funding Update: 2013 – 2015September 10, 2013

1

2China 2013

3

OVERVIEW

•MR Initiative Annual Expenditure 2001-2013

•MR Initiative Annual Donations 2001-2013; Financial

Resource Requirements through 2015

•MR Initiative Financial Resource Requirements - detail

•MR Initiative donors, 2001 - 2013

•measles & rubella moving ahead

•Challenges to implementation for MR Initiative

0

20

40

60

80

100

120

140

160

180

2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

$ U

S M

illi

on

Donations Series2

* Excluding country contributions

MR Initiative Annual Expenditure, 2001-2013

Total expenditure 2001-2013 = $1,008 million

4

1159

36 38 44

94

Measles & Rubella Initiative Annual Donations 2001-2015 and Financial Resource Requirements,

Projections, Funding Gap 2013-2015*

0

50

100

150

200

250

300

350

2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015

$ U

S M

illio

n

Donations Funds Projected or Pledged Funding gap (includes PSC)

* Excludes all country contributions and direct social mobilization funding from partners

5

0

50

100

150

200

250

300

350

400

2013 2014 2015

$ U

S M

illio

nMeasles & Rubella Initiative Financial Resource

Requirements, Projections, Funding Gap 2013-2015

Anticipated Country ContributionsDonor Funds Projected/Pledged/Received

32

31

18

47

Anticipated GAVI Contribution (Rubella)Funding Gap (includes PSC)

Total Funding Gap 2014-2015: US $65 million

6

Resource Requirements by Major Category of Activity, 2014-2015

0

50

100

150

200

250

300

350

400

2014 2015

$U

S M

illio

n

Measles SIAs Measles Rubella SIAs Technical Assistance Outbreak Response

Surveillance / Lab Coverage Surveys Research Communication

Total Cost 2014-2015: US $557 million

7

MR Initiative Donors, 2001-2013

* Includes ARC/UNF and other partners

CDCJICA

NorwayDFID

Civil SocietyARC*LDS

Lions

UNUNICEF

UNF*

FoundationsGates

Private SectorBD

MerckVodaphone

OtherGAVI/IFFIm

8

Where is the Measles & Rubella Initiative Headed?Toward regional achievement of Measles Rubella Elimination Goals by or before 2020

Improvement of routine coverage and timely and high quality SIAsExpanded use of accurate data for decision making

• 2012 measles goals: AFRO (pre-elimination) and WPRO (elimination) - missed

• 2013 potential SEARO elimination goal set (waiting), begin MR introduction campaigns with GAVI support (done)

• 2015 GIVS (95% mortality reduction) and MDG 4 goals; measles goal in EMRO and EURO (elimination); rubella goal in EURO (elimination); continue to set regional rubella elimination goals as appropriate

• 2020 Measles goal in AFRO (elimination)

Critical Elements for Success

• Political leadership

• Timely funding (donor and national governments)

• Adequate time for planning and social mobilization (9 months)

• Well performing surveillance, analysis & use of data to improve coverage9

Challenges to Implementation for MR Initiative

• Lack of timely and sufficient funding: few multiyear grants• Ensuring high quality SIA’s (increased training and social mobilization

cost, increased technical assistance request)• Providing strategic support for non-GAVI eligible countries (TA, Surveillance)

• Increased surveillance cost (including lab, coverage surveys)• Projecting target age range for SIA’s several years in advance• Projecting cost to MR Initiative for target populations above 59 months

for GAVI funded measles SIA’s in 6 large countries • Routine immunization: scale up of MCV1, increased MCV2 introduction

and coverage, other routine strengthening immunization activities

10

Anne Ray Charitable Trust

11